Literature DB >> 12370456

Alzheimer's disease can be accurately diagnosed in very mildly impaired individuals.

D P Salmon1, R G Thomas, M M Pay, A Booth, C R Hofstetter, L J Thal, R Katzman.   

Abstract

BACKGROUND: The growing propensity to diagnose AD in individuals with very mild cognitive impairment increases the danger of false-positive diagnostic errors. Unfortunately, there is little systematically acquired information about the accuracy of the AD diagnosis in very mildly impaired patients.
OBJECTIVE: To determine the accuracy of the diagnosis of AD in very mildly impaired patients and to identify objective measures that effectively distinguish these patients from elderly normal controls (NC).
METHODS: Consecutive patients with Mini-Mental State Examination scores of > or = 24 who received a clinical diagnosis of AD were evaluated annually for at least 3 years. The initial diagnosis was verified or refuted by autopsy or by information obtained in subsequent evaluations. Initial neuropsychological test scores of verified AD patients were compared with those of NC subjects to identify effective diagnostic measures.
RESULTS: The diagnosis of AD was confirmed in 98 of 110 (89%) very mildly impaired patients (33/36 by autopsy, 65/74 by disease progression). The diagnosis was inaccurate in 12 patients (11%): Seven were subsequently diagnosed with other neurologic disorders, and five were ultimately found to be normal. Neuropsychological measures of delayed recall, verbal fluency, and global cognitive status (i.e., Mattis Dementia Rating Scale) provided excellent sensitivity (> or = 96%) and specificity (> or = 93%) for differentiating between very mildly impaired AD patients and NC subjects.
CONCLUSIONS: When comprehensive assessment procedures are employed, AD can be diagnosed with reasonably high accuracy in very mildly impaired individuals. However, the dementia evaluation should be repeated after approximately 1 year to ensure the accuracy of the initial diagnosis.

Entities:  

Mesh:

Year:  2002        PMID: 12370456     DOI: 10.1212/wnl.59.7.1022

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  58 in total

1.  Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010.

Authors:  Thomas G Beach; Sarah E Monsell; Leslie E Phillips; Walter Kukull
Journal:  J Neuropathol Exp Neurol       Date:  2012-04       Impact factor: 3.685

2.  Driver landmark and traffic sign identification in early Alzheimer's disease.

Authors:  E Y Uc; M Rizzo; S W Anderson; Q Shi; J D Dawson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-06       Impact factor: 10.154

Review 3.  Cognitive aging and Alzheimer's disease.

Authors:  R Vandenberghe; J Tournoy
Journal:  Postgrad Med J       Date:  2005-06       Impact factor: 2.401

Review 4.  Neuropsychological contributions to the early identification of Alzheimer's disease.

Authors:  Mark W Bondi; Amy J Jak; Lisa Delano-Wood; Mark W Jacobson; Dean C Delis; David P Salmon
Journal:  Neuropsychol Rev       Date:  2008-03-18       Impact factor: 7.444

5.  Change blindness, aging, and cognition.

Authors:  Matthew Rizzo; Jondavid Sparks; Sean McEvoy; Sarah Viamonte; Ida Kellison; Shaun P Vecera
Journal:  J Clin Exp Neuropsychol       Date:  2008-12-03       Impact factor: 2.475

Review 6.  Neuropsychological assessment of dementia.

Authors:  David P Salmon; Mark W Bondi
Journal:  Annu Rev Psychol       Date:  2009       Impact factor: 24.137

7.  Decreased white matter integrity in neuropsychologically defined mild cognitive impairment is independent of cortical thinning.

Authors:  Nikki H Stricker; David H Salat; Jessica M Foley; Tyler A Zink; Ida L Kellison; Craig P McFarland; Laura J Grande; Regina E McGlinchey; William P Milberg; Elizabeth C Leritz
Journal:  J Int Neuropsychol Soc       Date:  2013-07-01       Impact factor: 2.892

8.  Neuropsychological Deficit Profiles, Vascular Risk Factors, and Neuropathological Findings in Hispanic Older Adults with Autopsy-Confirmed Alzheimer's Disease.

Authors:  Gali H Weissberger; Tamar H Gollan; Mark W Bondi; Daniel A Nation; Lawrence A Hansen; Douglas Galasko; David P Salmon
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 9.  Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment.

Authors:  Rukhsana Sultana; D Allan Butterfield
Journal:  J Bioenerg Biomembr       Date:  2009-10       Impact factor: 2.945

10.  The cognitive mechanisms underlying perspective taking between conversational partners: evidence from speakers with Alzheimer׳s disease.

Authors:  Liane Wardlow; Iva Ivanova; Tamar H Gollan
Journal:  Neuropsychologia       Date:  2014-01-24       Impact factor: 3.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.